Oscar Torres - Genomma Lab Insider

Genomma Lab Internacional S A B de C V -- Mexico Stock  

MXN 22.76  0.32  1.39%

Vice-President of Fin. and Admin.

Mr. Oscar Villalobos Torres served as Executive Vice President of Finance and Administration of Genomma Lab Internacional S.A.B. de C.V. till December 15 2015. Previously he acted as Chief Financial Officer of the Company from October 24 2008. He has also served at Grupo IMSA and International de Ceramica . He holds a Masters degree in Business Administration from Universidad Autonoma de Chihuahua a Bachelors degree in Finance and Management from the University of Texas a postgraduate degree in Corporationrationrate Law and International Business from Georgetown University a degree in Advanced Management from Instituto Panamericano de Alta Direccion de Empresa and a degree in Finance from Instituto Tecnologico y de Estudios Superiores Monterrey.
52 55 5081 0000  http://www.genommalab.com

Management Efficiency

The company has return on total asset (ROA) of 12.93 % which means that it generated profit of $12.93 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 15.99 % meaning that it generated $15.99 on every $100 dollars invested by stockholders.
The company has accumulated 5.8 B in total debt with debt to equity ratio (D/E) of 91.8 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Genomma Lab Internacional S A B de C V has Current Ratio of 1.49 which is within standard range for the sector.

Similar Executives

Entity Summary

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, develops, markets, and sells overthecounter pharmaceutical products, generic drugs, and personal care solutions in Mexico and internationally. Genomma Lab Internacional S A B de C V (LABB) is traded on Mexico Stock Exchange in Mexico. It is located in Mexico City, DF and employs 799 people.

Did you try this?

Run Portfolio Backtesting Now

Portfolio Backtesting

Avoid under-diversification and over-optimization by backtesting your portfolios
Hide  View All  Next  Launch Portfolio Backtesting
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Genomma Lab Internacional S A B de C V to your portfolio

Top Management

Genomma Lab Internac Leadership Team
Oscar Torres, Executive
Maximo Juda, CEO
Scott Emerson, Director
Stefano Curti, President
Tatiana Garcia, Director
Ramon Sastre, President
Marco Munoz, Director
Jorge Munoz, Director
Alejandro Patino, President
Leandro Gold, Director
Andres Labastida, Director, Ph.D
Jose Fernandez, Director
Rodrigo Aspra, Chairman
Claudia Vettoretti, President
Renata Aspra, COO
Miguel Gonzalez, President
Antonio Galland, CFO
Luis MacKissack, Director
Arturo Perez, Director
Hector Gonzalez, Director
Marco Sparvieri, EVP
Javier Castilla, Director
Ricardo Munoz, Director
Sabrina Aspra, Director
Juan Alonso, Director
Santiago Pelaez, President
Roberto Sauma, Director

Stock Performance

Genomma Lab Performance Indicators